After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of NewAmsterdam Pharma Company NV is $2.25B. A total of 0.73 million shares were traded on the day, compared to an average of 666.41K shares.
In the most recent transaction, ForGrowth NAP B.V. sold 166,011 shares of NAMS for 25.39 per share on Dec 12 ’24. After the transaction, the 10% Owner now owns 11,150,461 company shares. In a previous transaction on Dec 13 ’24, ForGrowth NAP B.V. sold 25,751 shares at 25.01 per share. NAMS shares that 10% Owner owns now total 11,124,710.
Among the insiders who sold shares, ForGrowth NAP B.V. disposed of 308,250 shares on Dec 10 ’24 at a per-share price of $25.37. This resulted in the 10% Owner holding 11,470,510 shares of NAMS after the transaction. In another insider transaction, ForGrowth NAP B.V. sold 154,038 shares at $25.46 per share on Dec 11 ’24. Company shares held by the 10% Owner now total 11,316,472.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, NAMS has a high of $27.29 and a low of $9.72.
As of this writing, NAMS has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.44 per share and a lower estimate of -$0.59.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NAMS’s latest balance sheet shows that the firm has $60.11M in Cash & Short Term Investments as of fiscal 2021. There were $185.68k in debt and $11.19M in liabilities at the time. Its Book Value Per Share was $4.11, while its Total Shareholder’s Equity was $56.37M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NAMS is Buy with a score of 4.78.
